GURUFOCUS.COM » STOCK LIST » USA » NAS » Grifols SA (NAS:GRFS) » Definitions » Revenue
Switch to:

Grifols Revenue

: $1,584 Mil (TTM As of Jun. 2022)
View and export this data going back to 2011. Start your Free Trial

Grifols's revenue for the three months ended in Jun. 2022 was $1,584 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2022 was $1,584 Mil. Grifols's Revenue per Share for the three months ended in Jun. 2022 was $3.75. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $3.75.

Warning Sign:

Grifols SA revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Grifols was -22.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Grifols's highest 3-Year average Revenue per Share Growth Rate was 51.60% per year. The lowest was -5.60% per year. And the median was 8.35% per year.


Grifols Revenue Historical Data

The historical data trend for Grifols's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,431.86 4,604.96 5,233.05 5,480.76 5,063.11

Grifols Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,343.83 1,215.95 1,387.52 - 1,583.56

Competitive Comparison

For the Drug Manufacturers - General subindustry, Grifols's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Grifols Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Grifols's Revenue distribution charts can be found below:

* The bar in red indicates where Grifols's Revenue falls into.



Grifols Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,584 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grifols  (NAS:GRFS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Grifols Revenue Related Terms

Thank you for viewing the detailed overview of Grifols's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols Business Description

Grifols logo
Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 77% of sales in 2021. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 15% of revenue following the Novartis and Hologic deals.

Grifols Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)